Research On The Formulation And Implementation Of Betta Pharmaceuticals Co.Ltd. Strategy

In recent years,domestic pharmaceutical enterprises that independently develop innovative drugs have mushroomed.This new type of pharmaceutical enterprises is gradually becoming the backbone of China's pharmaceutical industry.At this time,the single,traditional competition strategy has been unable to fully escort the development of new pharmaceutical enterprises.Only through to the emerging pharmaceutical enterprise internal and external environment of comprehensive thinking and analysis,its scientific and rational formulation and selection of effective competition strategy is one characteristic of improve the core competitiveness of enterprises.As the new domestic pharmaceutical companies deal with their domestic competitors,they also have to face the powerful attack of mature multinational companies that have been trained by the market.Therefore,the formulation and implementation of effective competition strategy is not the icing on the cake,but directly related to the survival of enterprises.Based on previous literature,on the basis of combing with BD Pharmaceuticals Co.,Ltd as the research object,using PEST analysis of the external environment of BD pharmaceutical analysis,using the SWOT analysis method to BD pharmaceutical internal strengths,weaknesses,external opportunities and threats were analyzed,and based on this,puts forward the four strategic choices: focus on developing cancer drugs business strategy,related diversification strategy,vertical integration strategy,horizontal integration strategy,in carries on the quantitative analysis by QSPM quantitative matrix,to score four alternative strategy,finally scored the highest for anticancer drugs mainly concentrated development strategy.After selecting the main industry strategy of developing anti-cancer drugs in the four alternative strategies,this paper further analyzed and sorted out the safeguard measures in various aspects needed to implement the strategy,which is the research content of the strategic implementation part of BD pharmaceutical.This article through to the BD Pharmaceuticals Co.,Ltd for qualitative and quantitative analysis,draws the following conclusion: represented by BD pharmaceutical domestic independent research and development of innovative medicine pharmaceutical enterprise in the face of more intense international competition under the premise of should grasp the opportunity to vigorously promote independent innovation in our country of centralized superior resources for independent research and development of new drugs,strengthen the core competitiveness,and with more technical independent innovation medicine to face the comprehensive competition of the multinational drug companies,as well as for Chinese people to make more use of good medicine.